These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8156526)

  • 1. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
    Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
    Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
    Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
    Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of argyrophilic nucleolar organizer region staining in predicting the behavior of meningiomas.
    Ahmadi SA; Samadi N
    Ann Saudi Med; 2006; 26(1):38-42. PubMed ID: 16521873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar organizer regions in meningiomas. Correlation with histopathologic malignancy grading, DNA cytometry and clinical outcome.
    Plate KH; Ruschoff J; Mennel HD
    Anal Quant Cytol Histol; 1990 Dec; 12(6):429-38. PubMed ID: 2078265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphometrical analysis of nucleolin immunohistochemistry in meningiomas.
    Ohkoudo M; Sawa H; Shiina Y; Sato H; Kamata K; Iijima J; Yamamoto H; Fujii M; Saito I
    Acta Neuropathol; 1996 Jul; 92(1):1-7. PubMed ID: 8811118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of argyrophilic nucleolar organizer staining for predicting prognosis of patients with recurrent soft tissue sarcoma.
    Kuratsu S; Ohsawa M; Naka N; Myoui A; Tomita Y; Uchida A; Ono K; Aozasa K
    Oncology; 1994; 51(3):244-50. PubMed ID: 8196907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
    Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
    Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleolar organizer regions in meningiomas.
    Radhakrishnan VV; Radhakrishnan NS; Rout D; Misna BK
    Br J Neurosurg; 1993; 7(4):377-81. PubMed ID: 8216907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive meningioma: a tumour with high proliferating and "recurrence" potential.
    Suwa T; Kawano N; Oka H; Ito H; Kameya T
    Acta Neurochir (Wien); 1995; 136(3-4):127-31. PubMed ID: 8748841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas.
    Zimmer C; Gottschalk J; Cervos-Navarro J; Martin H; Beil M; Jautzke G
    Pathol Res Pract; 1992 Dec; 188(8):951-8. PubMed ID: 1363764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management.
    Ohta M; Iwaki T; Kitamoto T; Takeshita I; Tateishi J; Fukui M
    Cancer; 1994 Dec; 74(12):3176-89. PubMed ID: 7982181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
    Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
    Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ag-NORs, nucleus-nucleolus-associated antigens (Ki67, PCNA, P-105 and p-120): prognostic markers of meningioma recurrence].
    Crafa P; Campanini N; Martella EM; Trabattoni G; Tedeschi F
    Acta Biomed Ateneo Parmense; 1994; 65(5-6):297-308. PubMed ID: 8592922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
    Korshunov A; Shishkina L; Golanov A
    Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
    Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
    Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AgNOR in neurooncology].
    Martin H; Gottschalk J; Hufnagl P; Beil M
    Acta Histochem Suppl; 1992; 42():179-84. PubMed ID: 1584963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIB-1 immunostaining and DNA flow cytometry in meningiomas.
    Yasue M; Akasaki Y; Numoto TR; Abe S; Abe T; Takeuchi Y; Tanaka J
    Noshuyo Byori; 1996 Apr; 13(1):17-20. PubMed ID: 8916122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.
    Demirtaş E; Yilmaz F; Ovül I; Oner K
    Acta Neurochir (Wien); 1996; 138(12):1456-63. PubMed ID: 9030354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.